Diantha Duvall - 02 Jun 2022 Form 4 Insider Report for GENOCEA BIOSCIENCES, INC. (GNCA)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Diantha Duvall
Issuer symbol
GNCA
Transactions as of
02 Jun 2022
Transactions value $
-$81
Form type
4
Filing time
03 Jun 2022, 16:13:21
Previous filing
26 May 2022
Next filing
10 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNCA Common Stock Sale -$81 -1.36K -1.77% $0.06* 75.4K 02 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person.